Arterial hypertension in a murine model of sleep apnea: Role of NADPH oxidase 2

Journal of Hypertension

Volumn 32, Issue 2, 2014, Pages 300-305

  Schulz, Richard ^a   Murzabekova, Gulsina ^a   Egemnazarov, Bakytbek ^a   Kraut, Simone ^a   Eisele, Hans Joachim ^a   Dumitrascu, Rio ^a   Heitmann, Jörg ^a   Seimetz, Michael ^a   Witzenrath, Martin ^b   Ghofrani, Hossein A ^a   Schermuly, Ralph T ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a,c   Weissmann, Norbert ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

arterial hypertension; mice; NADPH oxidase; sleep apnea

Indexed keywords

APOCYNIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ABDOMINAL AORTA; ADULT; AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CATHETER; CHRONIC INTERMITTENT HYPOXIA; FEMORAL ARTERY; GENE EXPRESSION; HEART; HYPERTENSION; MALE; MOUSE; MURINE MODEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SLEEP DISORDERED BREATHING;

ACETOPHENONES; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HYPERTENSION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; RNA, MESSENGER; SLEEP APNEA, OBSTRUCTIVE;

EID: 84892969411     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000016     Document Type: Article

References (36)

1. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 2000; 18:679-685.
2. Narkiewicz K, Somers VK. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens 1997; 15:1613-1619.
3. Bao G, Metreveli N, Li R, Taylor A, Fletcher EC. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 1997; 83:95-101.
4. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17:61-66.
5. Allahdadi KJ, Walker BR, Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005; 45:705-709.
6. Møller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-h blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16:274-280.
7. Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 2002; 92:627-633.
8. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162:566-570.
9. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165:934-939.
10. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea-response to CPAP therapy. Thorax 2000; 55:1046-1051.
11. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, Lam WK. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162:2166-2171.
12. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002; 397:342-344.
13. Van Heerebeek L, Meischl C, Stooker W, Meijer CJ, Niessen HW, Roos D. NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol 2002; 55:561-568.
14. Griendling KK, Sorescu D, Ushio-Fukai M. NADPH oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86:494-501.
15. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38:1395-1399.
16. Landmesser U, Harrison DG, Drexler H. Oxidant stress- A major cause of reduced endothelial nitric oxide availability in cardiovascular disease. Eur J Clin Pharmacol 2006; 62 (Suppl. 1):13-19.
17. Liu H, Liu K, Zhou Y, Xu Y. Relationship between reduced nicotina-mide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population. Chin Med J 2009; 122:1369-1374.
18. Del Ben M, Fabiani M, Loffredo L, Polimeni L, Carnevale R, Baratta F, et al. Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulm Med 2012; 12:36.
19. Fortuno A, Olivan S, Beloqui O, San Jose G, Moreno MU, Diez J, Zalba G. Association of increased phagocytic NADPH oxidase-depend-ent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 2004; 22:2169-2175.
20. Maeda K, Yasunari K, Sato EF, Yoshikawa J, Inoue M. Activation of protein kinase C and nicotinamide adenine dinucleotide phosphate oxidase in leukocytes of spontaneously hypertensive rats. Hypertens Res 2003; 26:999-1006.
21. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005; 69:221-226.
22. Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W, Schulz R. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006; 173:897-901.
23. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvanna-kitti D, Prabhakar NR. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 2006; 575:229-239.
24. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V, Kanagy NL. Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 2007; 293:H2971-H2976.
25. Del Rio R, Moya EA, Iturriaga R. Carotid body and cardiorespiratory alterations in intermittent hypoxia: the oxidative link. Eur Respir J 2010; 36:143-150.
26. Yuan G, Khan SA, Luo W, Nanduri J, Semenza GL, Prabhakar NR. Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol 2011; 226:2925-2933.
27. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, et al. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 2006; 577:705-716.
28. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148:399-408.
29. Lam SY, Liu Y, Ng KM, Lau CF, Liong EC, Tipoe GL, Fung ML. Chronic intermittent hypoxia induces local inflammation of the rat carotid body via functional upregulation of proinflammatory cytokine pathways. Histochem Cell Biol 2012; 137:303-317.
30. Jun J, Savransky V, Nanayakkara A, Bevans S, Li J, Smith PL, Polotsky VY. Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiol Regul Integr Comp Physiol 2008; 295:R1274-R1281.
31. Ramond A, Godin-Ribuot D, Ribuot C, Totoson P, Koritchneva I, Cachot S, et al. Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia. Fundam Clin Pharmacol 2013; 27: 252-261.
32. Wang WY, Zeng YM, Chen XY, Zhang YX. Effect of telmisartan on local cardiovascular oxidative stress in mouse under chronic intermittent hypoxia condition. Sleep Breath 2013; 17:181-187.
33. Rupin A, Paysant J, Sansilvestri-Morel P, Lembrez N, Lacoste JM, Cordi A, Verbeuren TJ. Role of NADPH oxidase-mediated superoxide production in the regulation of E-selectin expression by endothelial cells subjected to anoxia/reoxygenation. Cardiovasc Res 2004; 63:323-330.
34. El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E, Miller N. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006; 27:997-1002.
35. Hayashi T, Yamashita C, Matsumoto C, Kwak CJ, Fujii K, Hirata T, et al. Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress. Am J Physiol Heart Circ Physiol 2008; 294:H2197-H2203.
36. Nisbet RE, Graves AS, Kleinhenz DJ, Rupnow HL, Reed AL, Fan TH, et al. The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice. Am J Respir Cell Mol Biol 2009; 40:601-609.